Press Release

HAYA Therapeutics Completes CHF 18 Million Seed Financing to Advance Anti-fibrotic Therapies Targeting Long Non-Coding RNAs

May 20, 2021

HAYA Therapeutics Completes CHF 18 Million Seed Financing to Advance Anti-fibrotic Therapies Targeting Long Non-Coding RNAs
Press Release

HAYA Therapeutics Completes CHF 18 Million Seed Financing to Advance Anti-fibrotic Therapies Targeting Long Non-Coding RNAs

May 20, 2021